整合素信号的方向切换和一个新的抗血栓战略
Bo Shen1, Xiaojuan Zhao, Kelly A O'Brien
1Department of Pharmacology, University of Illinois at Chicago, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
Nature
|October 29, 2013
概括
研究人员发现了一种控制整合素信号传递的新机制,这导致了一种新的抗血栓性药物. 这种药物向Gα13-整合素相互作用,抑制动脉血栓形成,而不会增加出血风险.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 整合素在血栓形成和血液静止中至关重要.
- 目前的整合素αIIbβ3抗剂是有效的,但会导致出血.
- 开发更安全的抗血栓剂是一个关键的医疗需求.
研究的目的:
- 为了阐明整体的双向信号机制.
- 为了确定开发抗血栓性药物的新目标,而无出血副作用.
主要方法:
- 研究了塔林和Gα13与整合素β3细胞质域的结合.
- 使用基于EXE动机的抑制剂来阻止Gα13-整合素相互作用.
- 在体内对整合素信号传递,血小板扩散,血栓形成和出血时间的评估影响.
主要成果:
- 塔林和Gα13以顺序的方式与整合素β3的不同部位结合.
- 内向外信号涉及初始的塔林结合;外向内信号需要Gα13与EXE动机结合.
- 一种EXE动机抑制剂选择性地阻断了外进信号,抑制了动脉血栓,并没有延长出血时间.
结论:
- 确定了一个用于定向整合素信号交换机的新型机制.
- 可以开发一类新的针对Gα13-整合素相互作用的抗血栓性药物.
- 这种方法为有效的血栓形成治疗提供了有希望的策略,降低了出血风险.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Blood Pressure Imbalances and Circulatory Shock
1.8K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598


